Authors


Ted Lain, MD, MBA, FAAD

Latest:

Case 2: Male, 58-Years-Old

An expert in dermatology presents the case of a 58-year-old male who has struggled with long-standing atopic dermatitis. The presentation delves into the considerations between topical and systemic treatments and sheds light on the intricacies of managing patients with comorbidities, extensive treatment histories, and the challenges posed by prior authorizations.


Elianna Goldstein

Latest:

Aircrews Face Increased Risk of Developing Skin Cancer

Frequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.


Jeffrey Cizenski, MD, FAAD

Latest:

Jeffrey Cizenski, MD, FAAD: Eczema Representation Through Under My Skin Documentary

In this expert Q&A, dermatologist Jeffrey Cizenski, MD, FAAD, offers perspectives on National Eczema Awareness Month and AbbVie's Under My Skin documentary.


Jill Murphy

Latest:

Dupilumab Demonstrates Long-Term Safety for Moderate to Severe AD

The fully human monoclonal antibody is currently approved in more than 60 countries.


Terry Arnold, PA-C

Latest:

Top 5 Strategies to Switch From Practice to Pharma

Terry Arnold, PA-C, shares a wide range of opportunities to take clinical experience to a different setting and tips to transition.




Aubrie Jones, PA-C, MMS

Latest:

Fostering Mentorship and Support in Early-Stage Physician Assistants

Aubrie Jones, PA-C, MMS, and Laura Bush, DMSc, PA-C, DFAAPA, discuss the role of the SDPA in supporting the growth and journeys of PAs at all stages.


Christoph R. Loeser, MD, IFAAD

Latest:

Dermatologist Shares Insights on Saving the Nail at Annual Meeting

What's new in the treatment of mucoid pseudocysts? An international researcher and clinicians shares insights.


Jeremy Youse, M.D.

Latest:

Optimize your dermatology practice by prioritizing these 5 tasks

Jeremy Youse, M.D., founding partner, medical director and practicing dermatologist at VitalSkin Dermatology discusses which tasks he and other dermatologists want control over to get the most out of practicing and running their offices efficiently each day.


Robert Sidbury, MD, MPH

Latest:

Comparing AD Guidelines From Around the World

Robert Sidbury, MD, MPH, addresses the similarities and differences between the AAD’s recent atopic dermatitis guidelines and other guidelines from various groups and countries.



Colleen Hall

Latest:

Access to Mohs Surgeon a Barrier to Referral

A survey asked dermatologists whether they had personal treated head and neck melanoma with excision, and if and when they referred patients with melanoma on the head and neck to a Mohs surgeon.


Partner Content

Latest:

A Revolutionary Way to Revive Sensitive Skin

With the release of three brand-new products, ALASTIN Skincare® is introducing a new line of sensitive skin products that include our proprietary TriHex Technology® along with other active ingredients.


Bob Peelman, CFP

Latest:

Resiliency: A Fundamental Success Factor in Any Financial Plan

Check out these 5 factors that can significantly impact a dermatologist’s financial plan and should therefore incorporate flexibility and resiliency to structure the plan for long-term success.


Hawasatu Dumbuya, PhD

Latest:

Prebiotic Skin Care’s Effectiveness in AD for SOC Patients

A prebiotic cleanser and moisturizer regimen not only significantly alleviated the severity of atopic dermatitis and xerosis, but also uncovered crucial differences in symptom experiences.


Matthew J. Elias, DO

Latest:

New Tech for Skin

There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.


Armand Butera

Latest:

Allergic Contact Dermatitis Common Among Children Exposed to Cobalt

Investigators suggest parents and clinicians should be mindful of children with suspected ACD with a history of exposure to jewelry, clothing, and belts with cobalt.


Conor Killmurray

Latest:

Lenvatinib/Pembrolizumab Demonstrates Continuing Efficacy in Advanced Melanoma

Lenvatinib and pembrolizumab continued to yield meaningful and durable responses in patients with advanced melanoma who had progressed on previous PD-L1 inhibitor treatment.


Albert C. Yan, MD, FAAP, FAAD

Latest:

PODCAST: Navigating Artificial Intelligence in Medicine Featuring Albert Yan, MD, FAAP, FAAD

In this episode, Albert Yan, MD, FAAP, FAAD, discusses his SPD 2024 session revolving around the helpful (or hindering?) role of artificial intelligence and chatbots in dermatology.


Cynthia Elliott, MD

Latest:

Cynthia Elliott, MD, Discusses Correlation Between Cosmetic Procedures and the COVID-19 Pandemic

Physicians across the US saw an uptick in cosmetic procedures after workers returned to offices.


Ruchi Gupta, MD, MPH

Latest:

Ruchi Gupta, MD, MPH: Challenges and Opportunities in Managing AD in College

Ruchi Gupta, MD, MPH, shares tips for supporting a successful transition to college for patients with atopic dermatitis.


Emma Andrus, Assistant Editor

Latest:

Discovering Last Month's Psoriasis Spotlight

The September 2023 issue of Dermatology Times featured a spotlight on psoriasis research, advances, and treatment options in patients with skin of color. Learn more about the topics covered in each spotlight article.

© 2024 MJH Life Sciences

All rights reserved.